Search

everythinglearnresearchcommunity

for

Search:↓

Biochanin A from soy is a promising and safe candidate for treating hair loss.

Fesoterodine is effective and safe for elderly patients with overactive bladder.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Tranexamic acid effectively reduced swelling episodes in a girl with a rare form of hereditary angioneurotic edema.

The formulated gel is a promising treatment for alopecia areata.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

Promising cancer treatments were found, but the manufacturer closed.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

MK-5108 is safe and shows potential against tumors, especially alone.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

Ondansetron can cause serious allergic reactions, so use it carefully.

Female rats showed more panic-related behavior than males, influenced by hormonal cycles and certain drugs.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.